Results 101 - 120 of 216.

Life Sciences - Health - 27.03.2018
BIABooster : a more sensitive device for characterizing DNA in blood circulation
BIABooster : a more sensitive device for characterizing DNA in blood circulation
Developed and patented 1 in 2012 and 2014 in the Laboratoire d'Analyse et d'Architecture des Systèmes (LAAS-CNRS) and implemented industrially by Picometrics-Technologies, BIABooster technology can characterize DNA with new precision and sensitivity. When used to analyze residual DNA circulating in the blood, it has identified promising signatures for monitoring patients with cancer.

Health - 26.03.2018
How to make a good impression when saying hello
How to make a good impression when saying hello
You can hear the perfect hello. And now you can see it too. Researchers from the CNRS, the ENS, and Aix-Marseille University 1 have established an experimental method that unveils the filter—that is, mental representation—we use to judge people when hearing them say a word as simple as “hello”. What is the ideal intonation for coming across as determined or trustworthy? This method is already used by these researchers for clinical purposes, with stroke survivors, and it opens many new doors for the study of language perception.

Life Sciences - Health - 19.03.2018
How allergens trigger asthma attacks
How allergens trigger asthma attacks
A team of Inserm and CNRS researchers from the Institute of Pharmacology and Structural Biology—or IPBS (CNRS / Université Toulouse III—Paul Sabatier)—have identified a protein that acts like a sensor detecting various allergens in the respiratory tract responsible for asthma attacks.

Health - 12.03.2018
A new solution for chronic pain
A new solution for chronic pain
Neuropathic pain is a chronic illness affecting 7-10% the population in France and for which there is no effective treatment. Researchers at the Institute for Neurosciences of Montpellier (INSERM/Université de Montpellier) and the Laboratory for Therapeutic Innovation (CNRS/Université de Strasbourg) have uncovered the mechanism behind the appearance and continuation of pain.

Life Sciences - Health - 12.03.2018
A sobering conclusion: Adult hearts contain no stem cells
A sobering conclusion: Adult hearts contain no stem cells
Marie Bannier, a former normal student in the Biology Department at the ENS de Lyon, participated in the research and writing of this scientific publication as part of her 4th year. During a myocardial infarction, commonly known as a heart attack, the blood supply to part of the heart muscle is cut off.

Health - Life Sciences - 30.01.2018
GlutN: understanding gluten sensitivity to offer suitable wheat-based products
GlutN: understanding gluten sensitivity to offer suitable wheat-based products
Coordinated by INRA, the GlutN Project aims to explore the mechanisms of non-celiac gluten sensitivity (NCGS), assess its prevalence and identify clinical markers with the goal of developing suitable bread products. The GlutN Project was launched on 30 January 2018 in Paris. Found in the grains of numerous cereals, including wheat, gluten is a composite of proteins which gives flour the viscoelastic properties it needs to add shape to bread products.

Health - 10.11.2017
The consumption of antioxidant-rich foods is associated with a lower risk of type 2 diabetes
A lower risk of type 2 diabetes has been observed among individuals consuming food rich in antioxidants. This effect is largely contributed by fruit, vegetables, tea and other hot beverages, as well as moderate consumption of alcohol, as shown in a recent study from an Inserm research group, published in Diabetologia , the journal of the European Association for the Study of Diabetes (EASD).

Health - Life Sciences - 03.11.2017
Antibiotics affect the efficacy of immunotherapy
A study published in the journal Science by a research team from Gustave Roussy, INSERM, INRA, AP-HP, IHU Médiaterranée Infections* and Paris-Sud University shows that prescribed antibiotics impair the efficacy of immunotherapy in cancer patients. It is important to consider that more than 20% of patients living with cancer receive antibiotics.

Health - Life Sciences - 26.10.2017
Discovery of a potential therapeutic target to combat trypanosomes
Discovery of a potential therapeutic target to combat trypanosomes
Yaser Hashem's team at the Laboratoire Architecture et Réactivité de l'ARN at CNRS's has discovered a new potential therapeutic target – located in the ribosome – to combat trypanosomes parasites.

Health - Computer Science - 13.10.2017
Augmented tongue ultrasound for speech therapy
Augmented tongue ultrasound for speech therapy
A team of researchers in the GIPSA-Lab (CNRS/Université Grenoble Alpes/Grenoble INP) and at INRIA Grenoble Rhône-Alpes has developed a system that can display the movements of our own tongues in real time.

Health - Life Sciences - 12.10.2017
BioPrint: Inserm Launches its Second Accelerator of Technological Research
The creation of accelerators of technological research (ART) is a priority of Inserm's strategic plan.

Life Sciences - Health - 11.10.2017
Identification of a molecular mechanism associated with schizophrenia and bipolar disorder
A research team in psychiatry at CEA-Neurospin, together with the Mondor Institute of Biomedical Research (INSERM) and the Henri-Mondor (AP-HP) university hospitals, has shown that a genetic variant associated with several psychiatric conditions alters a prefrontal-limbic network, which may increase the risk of developing schizophrenia or bipolar disorder.

Health - Environment - 10.10.2017
When anemones bleach, clownfish suffer
When anemones bleach, clownfish suffer
The bleaching of corals is a well-known consequence of climate change.

Health - Life Sciences - 09.10.2017
Type 1 diabetes and the microbiota : MAIT cells as biomarkers and new therapeutic targets
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded by modification of MAIT lymphocytes. These cells—associated with mucosae and able to recognize elements of the microbiota—could therefore serve as new biomarkers for early detection and prevention of the illness.

Health - Life Sciences - 06.10.2017
Colon cancer: APC protein affects immunity by preventing pre-cancerous inflammation
Adenomatous polyposis coli (APC) is a gene whose mutations are associated with a rare, hereditary form of colorectal cancer known as familial adenomatous polyposis.

Life Sciences - Health - 04.10.2017
Cell death by necrosis is not an accidental process
Cell death by necrosis is not an accidental process
Drosophila testes visualized by confocal microscopy. Necrotic germ cells are visualized in red (white arrowheads), cell nuclei in blue. Victor Girard Cell death allows elimination of supernumerary cells during development or of abnormal cells throughout life. Physiological cell death is tightly regulated to prevent pathologies such as degenerative diseases or cancers, which often occur due to excessive or absent cell death, respectively.

Health - Psychology - 02.10.2017
Prenatal exposure to endocrine disruptors and behavioral problems in children
An epidemiological study carried out by Inserm on families from the EDEN cohort (500 boys born between 2003 and 2006 and their mothers) shows that exposure during pregnancy to certain phenols and phthalates is associated with behavioral problems in boys between 3 and 5 years of age. The most worrying compounds in this respect are bisphenol A, triclosan and dibutyl phthalate (DBP).

Health - Life Sciences - 28.09.2017
How do arteries protect themselves from atherosclerosis?
Associated with an aging population and the development of metabolic syndrome, atherosclerosis is a leading cause of death worldwide. Researchers from Inserm Unit 970, the "Paris Cardiovascular Research Center" (Inserm/Université Paris Descartes), have succeeded in revealing the mechanisms underlying the formation of atherosclerotic plaques.

Health - Life Sciences - 21.09.2017
"Humanized" Mouse Model Developed to Study Hepatitis B Infection
The ANRS consortium "Humanized Mouse Models for Viral Hepatitis"1, made up of 6 teams of researchers, has developed a mouse model for studying the interaction between the immune system and the liver following infection by the hepatitis B virus. This research, coordinated by Dr. Hélène Strick-Marchand (Inserm joint unit 1223, "Physiopathology of the Immune System", Institut Pasteur), responds to a real lack of animal models for studying this disease and thus opens up the possibilities for evaluating new therapeutic strategies.

Health - 13.09.2017
Researchers Warn About Mixtures of Endocrine Disruptors During Pregnancy
A new study led by Inserm researchers from Irset, the Research Institute for Environmental and Occupational Health, [1 ] shows for the first time in humans that simultaneous exposure to endocrine disruptors exacerbates the effects observed from exposure to each chemical independently. This study focused principally on the human fetal testes and the potential consequences of these mixtures on development of the reproductive system, as the selected chemicals inhibited testosterone production.

This site uses cookies and analysis tools to improve the usability of the site. More information. |